The thyroid gland is believed to be under the humoral control of thyrotrophin (TSH)produced from the adenohypophysis, and it seems to us that the regulating center which controls the function of the pituitary-thyroid system exists in the anterior hypothalamus. Greer(1952) , Bogdanove and Halmi(1953) and others reported that the effect of the thiouracil administration which should normally cause an enlargement of the thyroid gland was inhibited by destruction of the anterior hypothalamus between the ventromedial hypothalamic and the suprachiasmatic nuclei.This suggests that the anterior hypothalamus has a close connection with the secretion of TSH.
On the other hand, Harper and Marttis(1950) , Jensen and Clark (1951) and others reported that radioactive thyroxine was accumulated in large amounts in the region of median eminence and neurohypophysis after its parenteral adminstration.
It seems likely that changes in the serum level of thyroxine have direct actions not only on the cells of adenohypophysis,but also on the anterior hypothalamus giving rise to the secretion of TSH. Von Euler and Holmgren (1956, a) , however, observed the inhibition of TSH secretion together with decrease in the blood level of thyroxine,after the local injection of thyroxine into the adenohypophysis,and stated a possibility that thyroxine acts upon adenohypophyseal level directly and not through feed back control by the hypothalamus. Ottaviani and Azzali(1956) , Azzali (1956) found a lipoid factor controlling the thyroid gland presenting in the hypothalamus. Shibusawa et al.(1956 a,b,c) declared the existence of a hypothalamic factor acting upon the pituitary-thyroid axis(so-called TRF)and postulated the humoral regulation of the pituitary-thyroid system.TRF was ultimately excreted into the urine.The authors attempted, thereupon,to pursue the changes in the amounts of TRF excreted in urine under various states of the function of the thyroid. 
RESULTS
1. Column chromatography with crude TRF, As shown in Figure 1 ,nine peaks were observed in elution curve after elution with 220ml of the effluent.The site of each peak was somewhat different according to the size of particles of Dowex-50-X4 and the length of column.PH of the influent buffer was more important.The thyroid stimulating effects of each fraction were tested with bioassay,and it was proved that the peak IX(so-called T9) was the sole active one,as shown in Figure 2 .
1.0ml of fraction peak IX (T9) was injected intramuscularly into male rats once daily for seven days. After the injections increase in the weight of the thyroid by 32% was observed. The same doses of the fraction peak IX(T9)was injected intraperitoneally into male rats. Twenty-four hrs. after injection,the uptake of I131 in the thyroid also increased (Table 1) .Activity of the peak IX(T9)can be expressed as TSH units as will be described in following paper. In this paper, T9 value is expressed as mM equivalent to leucine.
*From 180ml to 210ml,the grand peak of fraction corresponds to TRF(T9). Neck counts of rats were determined 40 hrs.after the intraperitoneal injection of 2 pc of 1131.After first 6 hrs.,the changes in the neck counts,namely the release rate of 1131 were remarkably enhanced in rats injected with T9 as compared with that in control group. Fig.2 .
Release of I131 from the thyroid gland after the injection of T9 
Changes in the urinary excretion of T9(TRF)in various conditions
The amount of T9 excreted in urine in one day was varied in various functional conditions of the thyroid as shown in Table 2 .
As a control,a patient was chosen,who was in reconvalescence from the fracture of the right femur and under training for walking.
The dermatologic patients receiving 20 mg of prednisone daily for 3 to 10 days showed some decrease in the urinary excretion of T9 fraction.
Patients immediately after the operative invasion or traumatic injury,the amount of T9 excreted into urine could be also observed to decrease.The levels of PBI in the patients in whom prednisone was given,and the postoperative patients were lower than that of the patient above described as control.
Healthy volunteers showed an increase of T9 value in urine after the continued administration of MTU(0.6g daily)for 5 days. However, the level of PBI rather decreased. Ottaviani and Azzali (1956) , and Azzali (1956) stated that lipoid fraction obtained from the hypothalamus has a thyroid-regulating action. The authors, however, recognized the regulating factor in the polypeptide fraction of the anterior hypothalamus as described in text and obtained a single spot of most effective property, so-called T9 fraction.
As well known,the administration of cortisone inhibits the secretion of TSH as well as the uptake of I131 in the thyroid. Woodbury (1951), and Epstein (1953) reported that cortisone inhibit the release of TSH, on the contrary, Hill et al.(1950), and Halmi (1953) threw doubt on such inhibition. Why such confusion occurs? One of the reason may be attributed to the accelerating activity of cortisone to excrete I131 from the kidney, as Bogoroch and Trimiras (1951), Ingbar (1953) and others reported.
The observation standing only upon the data of uptake of I131 in the thyroid is rather misleading. Brown-Grant, Harris and Reichlin (1954, a) reported that the release of I131 from the thyroid is strongly inhibited by administration of cortisone in rabbit, suggesting the inhibition of the secretion of TSH. The abovementioned result of the urinary excretion of TRF shows that cortisone may inhibit the secretion of TRF from the hypothalamus and consequently inhibit the secretion of TSH from the hypophysis.
Surgical stress is also considered to inhibit the function of the thyroid. The data obtained by us may explain the sequence that stress caused by operation or traumatic injury accelerates the secretion of ACTH, and inhibit the secretion of TRF as its secondary reaction.
In 2cases of hyperthyroidism treated with mercaptoimidazole for 10 to 14days, clinical improvement was recognized and together followed by the concurrent decrease in the urinary excretion of T9 fraction.
MTU, given to healthy volunteers, caused a marked increase in T9 excretion. The phenomenon that thiouracil causes increase in the release of TSH has been accepted as a rule. The effect of thiouracil to cause the hyperplasia of the thyroid was also inhibited by the interception of the linkage between the ventromedial hypothalamic and suprachiasmatic nuclei as reported by Greer (1952) , Bogdanove and Halmi (1953) and others. Martini (1954) observed that the action of PTU was exhibited through the hypothalamic-neurohypophyseal axis. Shibusawa (1956b) found the acceleration of neurosecretion when MTU was given in rats. These findings show good coincidence with our present observation concerning the increase in T9 excretion after the administration of MTU. In the case of puberty goiter, the amount of the urinary excretion of T9 fraction also increased remarkably. After the administration of mercaptoimidazole in the patients with hyperthyroidism, T9 value excreted in urine decreased moderately. Whether this might be attributed to the ineffectiveness of mercaptoimidazole hypothalamic center or not must await further investigations. 
